Paclitaxel | Docetaxel | Irinotecan | 10-DAB III | Baccatin | Sequoyitol | (2R,3S)-3-Phenylisoserine Hydrochloride | (4S,5R)-3-(tetra-butoxycarbonyl)-2,2-dimethyl-4-phenyl-oxazolidine-5-carboxylic acid | (4S,5R)-3-(3-benzoyl)-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic acid--Shanghai Jinhe Bio-Tech Co., Ltd.

username:

password:

Jinhe’s research and development center was set up in Shanghai Juke Bio-tech Park

Jinhe’s research and development center was set up in Shanghai Juke Bio-

tech Park on June 2006. 1 million RMB was invested in the res earch and

development center, it has a 400 square meters research and development

laboratory, and also has various xperimental and analyti cal equipments, the

center has 9 personnel, 8 of them has got bachelor’s degree and above,

welcome to join us.

	Welcome to visit our booth at CPHI Milan 2007
	Welcome to visit us during CPHI-INDIA 2007 at our booth: B6.
	Our Project Docetaxel is ranked as Innovation fund for Technology Based Firms Projects.
	Jinhe, was granted as the honor of “2005-2006 year’s advanced private enterprise “
	Mr. Zhang Weizhong, the General Manager of Jinhe Bio-tec is entitled as "Science and Technology Hero".
	One of Jinhe's patent gained the "Invention and creation patent prize of Qingpu District"
	Jinhe’s research and development center was set up in Shanghai Juke Bio-tech Park
	Mr. Zhang Weizhong wins the prize of "Shanghai Excellent Entrepreneur for Invention Implement".
	A new patent of Jinhe Bio-Tec called "a new method of Docetaxel synthesis" was published.